Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Food and Drug Administration Commissioner Stephen Hahn. Photo: Kevin Dietsch-Pool/Getty Images
The Food and Drug Administration on Friday ousted its top spokesperson, Emily Miller, after less than two weeks on the job, reports the New York Times.
Why it matters: Miller's removal comes amid disagreements over the FDA's communication strategy and controversy surrounding its emergency use authorization of convalescent blood plasma as a coronavirus treatment.
- "Effectively immediately, Emily Miller will no longer serve the FDA as the assistant commissioner for media affairs and will no longer be the official spokesperson for the agency. I will appoint someone to an acting role in that position in the interim," according to a memo from FDA Commissioner Stephen Hahn, obtained by Politico.
The big picture: Scientists and public health experts were up in arms after Hahn inflated the effectiveness of blood plasma as a COVID-19 treatment.
- Hahn owned up to a mistake while also addressing bigger-picture concerns about the FDA's political independence.
Worth noting: On Thursday, the Department of Health and Human Services ended the contract of Wayne L Pines, a public relations consultant who had advised Hahn to correct the misleading information on convalescent plasma.
- HHS told the Times that the termination of Pines' contract had nothing to do with the FDA's plasma messaging. It was "100 percent coincidence," Brian Harrison, the department’s chief of staff, said.
What's next: It's unclear whether Miller, a former reporter for One America News, will leave the administration completely or be reassigned elsewhere.